Insight

Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management

Photo from Michael Duruisseaux/X

Apr 11, 2024, 17:17

Michael Duruisseaux: Practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management

Michael Duruisseaux, Medical Director of the Joint Research Unit in Thoracic Oncology of the Hospices Civilians of Lyons, shared on X/Twitter:

“Just out on Lung Cancer Journal!
Based on the experience of two French expert lung cancer teams from Hospices Civils de Lyon and Institut Curie we propose practical guidance for sotorasib-related adverse events prevention and hepatotoxicity management.
Share your opinion!”

Proceed to the article.
Source: Michael Duruisseaux/X

cancer Hospices Civils de Lyon Institut Curie Lung cancer Lung Cancer Journal Michael Duruisseaux OncoDaily Oncology Sotorasib sotorasib-related adverse events

NEW PAPER ALERT: Efficacy of CDK4/6 Inhibitors and Endocrine Therapy in HR+/HER2- Advanced Breast Cancer by PAM50 Subtype: SOLTI-1801 CDK-PREDICT Results

Oncologist Near Me – Fabrice André: Leading Expert in Breast Cancer

Funding Impactful Cancer Research That Might Otherwise Go Unsupported: Ryan Schoenfeld on the Secret Behind Mark Foundation’s Success

One Hand Gives, Another Takes? Trump, Musk, Congress and Childhood Cancer Research Funding

Fabrice André has been elected as the President of the ESMO for the term 2025-2026

Special Coverage